𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retransplantation for donor-derived neuroendocrine tumor

✍ Scribed by Rehana Begum; Denise Harnois; Raj Satyanarayana; Murli Krishna; Kevin C. Halling; George P. Kim; Justin H. Nguyen; Andrew P. Keaveny


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
278 KB
Volume
17
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


Although tumor transmission through liver transplantation (LT) is a rare occurrence, the consequences can be devastating, even when a very aggressive management approach is adopted. We report the case of a donor-derived small cell neuroendocrine tumor (NET) in a patient who underwent LT for cholangiocarcinoma. Despite locoregional therapy, chemotherapy and ultimately retransplantation, the patient died from metastases. The high grade nature of the NET was the most important determinant of prognosis in this case. Our experience suggests that retransplantation for donor-derived NET should only be considered when tumor biology is favorable.


πŸ“œ SIMILAR VOLUMES


Liver transplantation for neuroendocrine
✍ Barbara Rosado; Gregory J. Gores πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 52 KB

Metastases from neuroendocrine tumors (NET) of the gastrointestinal tract, carcinoids, and endocrine pancreatic tumors (EPT) can be limited to the liver for long periods and may have slow growth. The symptoms are often related to hormone overproduction, and debulking surgery-for example, liver resec

Oncogene expression in gastroenteropancr
✍ Da-Gong Wang; Colin F. Johnston; Keith D. Buchanan πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 548 KB

## Background: Neuroendocrine tumors of the gastroenteropancreatic system include pancreatic islet cell and carcinoid tumors. these tumors comprise a functionally and biologically heterogeneous group of neoplasms that rarely show reliable histopathologic signs of malignancy. no etiologic factors ar